Rink et al. [14] found that the expression of the ZNF43, ZNF208, and ZNF91 genes was correlated with the response to imatinib mesylate in patients with gastrointestinal stromal tumor. This evidence concerns the gene ZNF208 and gastrointestinal stromal tumor.